Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FU950
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $113,583
Award facts
- Contract value 100% obligated
- $113,582.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $113,582.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pens on December 22, 2025, with completion targeted for December 23, 2025. This non-competitive set-aside delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication primarily used to treat moderate-to-severe atopic dermatitis, eosinophilic asthma, and chronic rhinosinusitis with nasal polyps, representing a specialized pharmaceutical product within the military healthcare supply chain.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.9 billion global pharmaceutical support vehicle extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, leverages this prime IDC to supply a broad range of medications, vaccines, and medical devices to military healthcare programs and the Defense Health Agency. The company's competitive positioning in federal medical procurement is demonstrated through its recurring delivery orders across multiple therapeutic domains, supporting critical military and veteran healthcare requirements.
Quick answers
Who was awarded contract SPE2DR26FU950?
SPE2DR26FU950 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FU950 worth?
The government has obligated $113,583 on SPE2DR26FU950.
Is contract SPE2DR26FU950 an order under another contract?
Yes. SPE2DR26FU950 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FU950 competed?
The extent of competition for SPE2DR26FU950 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award